Everyone should Have a look at the ACL website and do a bit of reading on their Liquid Biopsy test. From what I understand it misses one hell of a lot of CRC if it is not being caused by the specific mutations in the genes that they are testing. As for the other blood test you mentioned Galleri - do some research. Early cancer detection is abysmal - about 20%. No point in finding cancer when it is already at stage 4. Colostat is around 65% for stage 1 rising to around 85% for stage 2, no comparison what so ever especially when you consider the difference in the end costs. $400 for ACL for a test that misses around 45% of all CRC regardless of the stage, and $1000 for Galleri.
And I know what I am talking about because I just had a close relative die of CRC so I am very well aware of what was on offer. You are wrong, Colostat is miles ahead on every front. Detection at earlier stages and cost..I cant speak for their sales prospects in the current global climate but their test is by far the best for screening programs.
- Forums
- ASX - By Stock
- RHY
- Ann: Rhythm Maintains Ongoing ISO13485 Certification
Ann: Rhythm Maintains Ongoing ISO13485 Certification, page-35
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHY (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.90M |
Open | High | Low | Value | Volume |
7.0¢ | 7.0¢ | 6.8¢ | $696 | 10.22K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 6.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.0¢ | 12201 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.068 |
1 | 275 | 0.064 |
1 | 17000 | 0.060 |
2 | 24000 | 0.056 |
1 | 9091 | 0.055 |
Price($) | Vol. | No. |
---|---|---|
0.070 | 12201 | 2 |
0.071 | 107305 | 1 |
0.072 | 2245 | 1 |
0.076 | 117678 | 1 |
0.079 | 12495 | 1 |
Last trade - 14.53pm 16/08/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |